retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Targeting GLP-1, & GCG in and Type Diabetes Research retatrutide triple agonist glp-1 gip

10.3390/ijms17030367 5

Retatrutide goes further: GLP-1 appetite control, satiety, glucose regulation GIP improves insulin sensitivity, metabolic efficiency Glucagon increases energy expenditure & fat oxidation This combination may lead to greater fat loss with less muscle loss compared to GLP-1only drugs

Weekly injections maintain relatively stable blood levels

What to Do If Your Blood Sugar Drops Too Low Take 1520 g of fast-acting carbohydrate immediately, recheck blood glucose after 1015 minutes, and repeat if levels remain below 4 mmol/L

Here, when the two peptides were administered at a 30-min interval, the plasma concentration of the first peptide returned to baseline upon administration of the second peptide

The absence of these endpoints limits the ability to determine whether observed changes in lean mass translate into clinically meaningful impairments